SCHEMBL476942

SCHEMBL476942

[CH2]C(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28841410 1.00
Isobutyramide SCHEMBL18836923 0.77
Isobutyramide SCHEMBL11109750 0.75 LMNA (0.46)
Isobutyramide SCHEMBL3323 0.75
SCHEMBL1289823 0.74
SCHEMBL1289850 0.74
SCHEMBL7128203 0.74 TDP1 (0.32)
Isobutyramide SCHEMBL2402176 0.72
SCHEMBL10815842 0.72
SCHEMBL95564 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 714 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114727983-A Xanthine CB1 inhibitors 金翅雀生物公司 2022-07-08 CN claimed
WO-2021062089-A1 XANTHINE CB1 INHIBITORS GOLDFINCH BIO, INC. (US) 2021-04-01 WO claimed
CN-107400193-A A kind of application of new DOPO types compound in EP 武汉工程大学 2017-11-28 CN claimed
CN-104447450-B Cysteine amide-type pleuromutilin derivative and preparation method and medical usage 南通大学 2016-09-28 CN claimed
CN-104961666-A 2-mercaptoacetamide pleuromutilin derivatives, and preparation method and medical application thereof UNIV NANTONG 2015-10-07 CN claimed
CN-104447450-A Cysteine amide type pleuromutilin derivative as well as preparation method and medical application thereof UNIV NANTONG 2015-03-25 CN claimed
EP-1133976-B1 Hair dye composition KAO CORP (JP) 2007-02-28 EP claimed
US-20060089355-A1 Methods of treating alzheimer's disease using aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides ELAN PHARMACEUTICALS, INC. 2006-04-27 US claimed
WO-2003103652-A1 METHODS OF TREATING ALZHEIMER’S DISEASE USING AROMATICALLY SUBSTITUTED ω-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO claimed
EP-1330443-A1 SUBSTITUTED PHENYLURACILS Bayer CropScience AG (DE) 2003-07-30 EP claimed
US-4665073-A HISTAMINE H2-ANTAGONISTS ICI AMERICAS INC. (GB) 1987-05-12 US claimed
EP-0060094-B1 GUANIDINE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-01-22 EP claimed
EP-0150099-A1 Guanidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-07-31 EP claimed
US-4496564-A HISTAMINE H-2 ANTIGONISTS ICI AMERICAS INC. (US) 1985-01-29 US claimed
EP-0050072-B1 CYCLOPROPYL METHYL PIPERAZINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPEUTICS INNOTHERA (FR) 1984-12-27 EP claimed
US-4447441-A ANTIHISTAMINE, ANTIULCER AND ANTISECRETORY AGENT IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-05-08 US claimed
EP-0060094-A2 Guanidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-15 EP claimed
EP-0060093-A2 Amide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-15 EP claimed
US-4113717-A Quaternized azo dyestuffs IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1978-09-12 US claimed
US-4014920-A N-cinnamylcarbamic acid esters CIBA-GEIGY CORPORATION (US) 1977-03-29 US claimed